Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06216301
Title LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC (LUNAR-2)
Acronym LUNAR-2
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NovoCure GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.